Elevated MMP-9 was independently associated with the risk of acute exacerbations in COPD in two well-characterized COPD cohorts of the SPIROMICS and COPDGene studies, indicating that MMP-9 may serve as a prognostic biomarker and potential therapeutic target in COPD [109]. Here, MMP9 is linked to chronic obstructive pulmonary disease.